MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Li, Qiong ^a,b   Zhang, Daoxiang ^a   Wang, Yongbin ^a   Sun, Pan ^a   Hou, Xiaodan ^a   Larner, James ^d   Xiong, Wujun ^c   Mi, Jun ^a,d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c Key Laboratory of Arrhythmias of Ministry of Education   (China)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN21 MICRORNA, HUMAN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; BASE PAIRING; CELL TRANSFORMATION; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN BINDING; RNA INTERFERENCE; RNA TRANSLATION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

ANIMALS; BASE PAIRING; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICRORNAS; NEOPLASMS; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; PROTEIN BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR BURDEN; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84879644246     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02038     Document Type: Article

References (44)

1. Dimanche-Boitrel, M. T. et al. In vivo and in vitro invasiveness of a rat coloncancer cell line maintaining E-cadherin expression: an enhancing role of tumorassociated myofibroblasts. Int J Cancer 56, 512-521 (1994). (Pubitemid 24094402)
2. Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005). (Pubitemid 40692295)
3. Olaso, E. et al. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26, 634-642 (1997). (Pubitemid 27392354)
4. Grum-Schwensen, B. et al. Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. Cancer Res 65, 3772-3780 (2005). (Pubitemid 40616355)
5. Kuperwasser, C. et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101, 4966-4971 (2004). (Pubitemid 38469186)
6. Bhowmick, N. A. et al. TGF-beta signaling in fibroblastsmodulates the oncogenic potential of adjacent epithelia. Science 303, 848-851 (2004). (Pubitemid 38174665)
7. Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59, 5002-5011 (1999). (Pubitemid 29472907)
8. Boire, A. et al. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120, 303-313 (2005). (Pubitemid 40222426)
9. Lochter, A. et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 139, 1861-1872 (1997). (Pubitemid 28079248)
10. Stetler-Stevenson, W. G., Aznavoorian, S. & Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion andmetastasis. Annu Rev Cell Biol 9, 541-573 (1993).
11. Sternlicht, M. D. et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137-146 (1999). (Pubitemid 29344902)
12. Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301-313 (2008).
13. Ross, R. Aging of the intercellular matrix in relation to the fibroblast connective tissue forming cells-a retrospective view. Scand J Clin Lab Invest Suppl 65, 33-44 (1974).
14. Ronnov-Jessen, L. & Petersen, O. W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 68, 696-707 (1993). (Pubitemid 23202798)
15. Denk, P. O., Hoppe, J., Hoppe, V. & Knorr, M. Effect of growth factors on the activation of human Tenon's capsule fibroblasts. Curr Eye Res 27, 35-44 (2003). (Pubitemid 36936345)
16. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 294, 853-858 (2001). (Pubitemid 33032103)
17. Krichevsky, A. M. & Gabriely, G. miR-21: a small multi-faceted RNA. J Cell Mol Med 13, 39-53 (2009).
18. Chan, J. A., Krichevsky, A. M. & Kosik, K. S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65, 6029-6033 (2005). (Pubitemid 40994386)
19. Iorio, M. V. et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65, 7065-7070 (2005). (Pubitemid 41161233)
20. Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103, 2257-2261 (2006). (Pubitemid 43271657)
21. Fulci, V. et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109, 4944-4951 (2007). (Pubitemid 46827793)
22. Lawrie, C. H. et al.MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121, 1156-1161 (2007). (Pubitemid 47101656)
23. Navarro, A. et al. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 111, 2825-2832 (2008).
24. Pezzolesi, M. G., Platzer, P., Waite, K. A. & Eng, C. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. Am J Hum Genet 82, 1141-1149 (2008). (Pubitemid 351615147)
25. Meng, F. et al.MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658 (2007). (Pubitemid 47187346)
26. Frankel, L. B. et al. Programmed cell death 4 (PDCD4) is an important functional target of themicroRNA miR-21 in breast cancer cells. J Biol Chem 283, 1026-1033 (2008).
27. Gabriely, G. et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28, 5369-5380 (2008).
28. Zhang, Z. et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88, 1358-1366 (2008).
29. Lu, Z. et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27, 4373-4379 (2008). (Pubitemid 352010003)
30. Wang, P. et al. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 69, 8157-8165 (2009).
31. de Oliveira, P. E., Zhang, L., Wang, Z.& Lazo, J. S. Hypoxia-mediated regulation of Cdc25A phosphatase by p21 and miR-21. Cell Cycle 8, 3157-3164 (2009).
32. Huang, T. H. et al. Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. J Biol Chem 284, 18515-18524 (2009).
33. Talotta, F. et al. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28, 73-84 (2009).
34. Thum, T. et al. Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. J Clin Invest 121, 461-462; author reply 462-463 (2011).
35. Liu, G. et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207, 1589-1597 (2010).
36. Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
37. Chau, B. N. et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 4, 121ra118 (2012).
38. Yang, J. H. et al. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 39, D202-209 (2011).
39. Davis, B. N., Hilyard, A. C., Lagna, G. & Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56-61 (2008). (Pubitemid 351931982)
40. Ito, Y. et al. Antagonistic effects of Smad2 versus Smad7 are sensitive to their expression level during tooth development. J Biol Chem 276, 44163-44172 (2001).
41. Zhao, J. et al. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis. Mech Dev 93, 71-81 (2000). (Pubitemid 30216497)
42. Fuchshofer, R., Stephan, D. A., Russell, P. & Tamm, E. R. Gene expression profiling of TGFbeta2-and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling. Exp Eye Res 88, 1020-1032 (2009).
43. Jazag, A. et al. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factorbeta. Oncogene 24, 662-671 (2005). (Pubitemid 40188570)
44. Jazag, A. et al. Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components. Nucleic Acids Res 33, e131 (2005).